U.S., Jan. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07354269) titled 'Phase IV Clinical Study of sIPV Administration in Adolescent and Adult Populations' on April 22, 2025.
Brief Summary: The goal of this clinical study is to compare the immunogenicity and safety of one dose of sIPV in adolescents or adults aged 7-50 years with that of three doses of DTaP-IPV-Hib Pentavalent Vaccine in Infants Aged 3 Months
Study Start Date: Sept. 26, 2025
Study Type: INTERVENTIONAL
Condition:
Poliomyelitis
Intervention:
BIOLOGICAL: sIPV
one dose of sIPV administered via intramuscular injection
BIOLOGICAL: DTaP-IPV-Hib
three doses of DTaP-IPV-Hib administered via intramuscular injection following the schedule...